Table 2 Results of the absorbed dose calculation to normal liver and to tumour
First administration | Second administration | |||
|---|---|---|---|---|
Lesion | Liver | Lesion | Liver | |
Mass (g) | 42.8 ± 2.5 | 711 ± 16 | 41.4 ± 2.5 | 711 ± 16 |
A0 (MBq) | 140 ± 23 | 1010 ± 220 | 131 ± 30 | 852 ± 253 |
Effective half-life (h) | 120 ± 22 | 41.43 ± 10.8 | 113.7 ± 22.85 | 39.7 ± 15 |
Time-integrated activity (MBq·h) | 24,280 ± 2389 | 60,370 ± 5225 | 21,444 ± 2480 | 48,853 ± 6741 |
S value (mGy/MBq·s) | (7.8 ± 0.5) × 10 -4 | (0.49 ± 0.01) × 10-4 | (8.0 ± 0.5) × 10-4 | (0.49 ± 0.01) × 10-4 |
Absorbed dose (Gy) | 68.0 ± 7.8 | 10.6 ± 1.0 | 62.1 ± 7.8 | 8.6 ± 1.2 |